N-Terminal Pro-B-Type Natriuretic Peptide for Predicting Coronary Disease and Left Ventricular Hypertrophy in Asymptomatic CKD Not Requiring Dialysis

American Journal of Kidney Diseases - Tập 46 - Trang 35-44 - 2005
Christopher R. deFilippi1, Jeffrey C. Fink1, Caitlin M. Nass1, Hegang Chen1, Robert Christenson1
1Departments of Medicine and Pathology, University of Maryland School of Medicine, Baltimore, MD.

Tài liệu tham khảo

Sarnak, 2003, Kidney disease as a risk factor for development of cardiovascular disease, Circulation, 108, 2154, 10.1161/01.CIR.0000095676.90936.80 Al Suwaidi, 2002, Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes, Circulation, 106, 974, 10.1161/01.CIR.0000027560.41358.B3 Dries, 2000, The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction, J Am Coll Cardiol, 35, 681, 10.1016/S0735-1097(99)00608-7 Mann, 2001, Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril, Ann Intern Med, 134, 629, 10.7326/0003-4819-134-8-200104170-00007 Shlipak, 2002, Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients, Ann Intern Med, 137, 555, 10.7326/0003-4819-137-7-200210010-00006 Go, 2004, Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization, N Engl J Med, 351, 1296, 10.1056/NEJMoa041031 Fried, 2003, Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals, J Am Coll Cardiol, 41, 1364, 10.1016/S0735-1097(03)00163-3 Keith, 2004, Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization, Arch Intern Med, 164, 659, 10.1001/archinte.164.6.659 Manjunath, 2003, Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community, J Am Coll Cardiol, 41, 47, 10.1016/S0735-1097(02)02663-3 Muntner, 2002, Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States, J Am Soc Nephrol, 13, 745, 10.1681/ASN.V133745 2002, K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification and stratification. Part 1. Executive summary, Am J Kidney Dis, 39, S17 Coresh, 2001, Prevalence of high blood pressure and elevated serum creatinine level in the United States, Arch Intern Med, 161, 1207, 10.1001/archinte.161.9.1207 Culleton, 1999, Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency, Kidney Int, 56, 2214, 10.1046/j.1523-1755.1999.00773.x Levin, 1996, Prevalent left ventricular hypertrophy in the predialysis population, Am J Kidney Dis, 27, 347, 10.1016/S0272-6386(96)90357-1 Reis, 2002, Mild renal insufficiency is associated with angiographic coronary artery disease in women, Circulation, 105, 2826, 10.1161/01.CIR.0000021597.63026.65 Maisel, 2002, Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure, N Engl J Med, 347, 161, 10.1056/NEJMoa020233 Lainchbury, 2003, Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath, J Am Coll Cardiol, 42, 728, 10.1016/S0735-1097(03)00787-3 McCullough, 2003, Sorting out the evidence on natriuretic peptides, Rev Cardiovasc Med, 4, S13 McCullough, 2003, B-Type natriuretic peptide and renal function in the diagnosis of heart failure, Am J Kidney Dis, 41, 571, 10.1053/ajkd.2003.50118 Cataliotti, 2001, Circulating natriuretic peptide concentrations in patients with end-stage renal disease, Mayo Clin Proc, 76, 1111, 10.4065/76.11.1111 Longitano, 2002, N-Terminal pro brain natriuretic peptide (NT-proBNP) predicts left ventricular function and mortality in hemodialysis patients but not cardiac death, J Am Coll Card, 39, 269A, 10.1016/S0735-1097(02)81208-6 Bibbins-Domingo, 2003, B-Type natriuretic peptide and ischemia in patients with stable coronary disease, Circulation, 108, 2987, 10.1161/01.CIR.0000103681.04726.9C Weber, 2004, N-Terminal B-type natriuretic peptide predicts the extent of coronary artery disease and ischemia in patients with stable angina pectoris, Am Heart J, 148, 612, 10.1016/j.ahj.2004.04.021 Foote, 2004, Detection of exercise-induced ischemia by changes in B-type natriuretic peptides, J Am Coll Cardiol, 44, 1980, 10.1016/j.jacc.2004.08.045 Levey, 1999, A more accurate method to estimate glomerular filtration rate from serum creatinine, Ann Intern Med, 130, 461, 10.7326/0003-4819-130-6-199903160-00002 2002 Lubien, 2002, Utility of B-natriuretic peptide in detecting diastolic dysfunction, Circulation, 105, 595, 10.1161/hc0502.103010 Devereux, 1986, Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy, Am J Cardiol, 57, 1388, 10.1016/0002-9149(86)90224-9 de Simone, 1992, Left ventricular mass and body size in normotensive children and adults, J Am Coll Cardiol, 20, 1251, 10.1016/0735-1097(92)90385-Z Gottdiener, 2002, Hypertension, 705 Vuille, 1994, Left ventricle. I: General considerations. Assessment of chamber size and function, 575 Takami, 2004, Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF, Am J Kidney Dis, 44, 420, 10.1016/S0272-6386(04)00812-1 Tateishi, 2000, Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty, Clin Cardiol, 23, 776, 10.1002/clc.4960231016 Kragelund, 2005, N-Terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease, N Engl J Med, 352, 666, 10.1056/NEJMoa042330 Luchner, 2002, N-Terminal pro-brain natriuretic peptide after myocardial infarction. A marker of cardio-renal function, Hypertension, 39, 99, 10.1161/hy0102.100537 deFilippi, 2003, Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis, JAMA, 290, 353, 10.1001/jama.290.3.353 Redfield, 2004, Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction, Circulation, 109, 3176, 10.1161/01.CIR.0000130845.38133.8F Hobbs, 2002, Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure, BMJ, 324, 1498, 10.1136/bmj.324.7352.1498 Feldman, 2003, The Chronic Renal Insufficiency Cohort (CRIC) Study, J Am Soc Nephrol, 7, S148, 10.1097/01.ASN.0000070149.78399.CE